Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
Primary hepatocytes are a valuable tool to study liver response and metabolism in vitro. Utilizing commercially available reagents, an improved time- and labor-efficient protocol for mouse primary hepatocyte isolation was developed.
Primary hepatocytes are used extensively in liver in vitro research, especially in glucose metabolism studies. A base technique has been adapted based on different needs, like time, labor, cost, and primary hepatocyte usage, resulting in various primary hepatocyte isolation protocols. However, the numerous steps and time-consuming reagent preparations in primary hepatocyte isolation are major drawbacks for efficiency. After comparing different protocols for their pros and cons, the advantages of each were combined, and a rapid and efficient primary hepatocyte isolation protocol was formulated. Within only ~35 min, this protocol could yield as much, if not more, healthy primary hepatocytes as other protocols. Further, glucose metabolism experiments performed using the isolated primary hepatocytes validated the usefulness of this protocol in in vitro liver metabolism studies. We also extensively reviewed and analyzed the significance and purpose of each step in this study so that future researchers can further optimize this protocol based on needs.
The liver serves as one of the most important organs in the vertebrate body due to the vital role it plays in numerous life-supporting functions like food digestion, blood circulation, and detoxification. Usage of mouse primary hepatocyte in vitro culture is increasingly popular in studies of carbohydrate metabolism and hepatic carcinoma. Therefore, it is important to develop a convenient method for mouse primary hepatocyte isolation while maintaining its innate physiological function. Due to its function as a hub of glucose metabolism, the liver is also central to glucose production and storage1. Experiments with primary hepatocytes in vitro are a must to most glucose metabolism studies. Therefore, for years, various research groups have developed protocols for mouse primary hepatocyte isolation.
The general procedure of mouse hepatocyte isolation is to first flush out blood in the liver with an isosmotic liquid such as phosphate-buffered saline (PBS) or Hanks' Balanced Salt Solution (HBSS) and then use collagenase-containing solution to dissociate hepatocytes. These protocols share a general procedure but differ in reagents and steps based on different needs. However, preparing required reagents and performing isolation steps take time. In developing the present protocol, efficiency was set as a priority, with all reagents ready-to-use and available from the market, and as few steps as possible. The overall goal of this protocol is to provide a fast and labor-efficient method to isolate primary hepatocytes from mouse, without jeopardizing the isolated primary hepatocyte purity and viability.
All procedures were approved by the Johns Hopkins Animal Care and Use Committee. C57BL/6 female mice (8-week old) were used in this study.
1. Preparation:
2. Procedure:
In order to test the efficiency, the present primary hepatocyte isolation protocol was performed on 8-week old female C57BL/6 mice. The attachment and purity of isolated primary hepatocytes were tested. Primary hepatocyte isolation is used for a wide variety of experiments on liver physiology, such as hepatic drug effects and glucose metabolism, pharmaceutical biomarker activity2, insulin sensitivity, and glucose production. Therefore, the activities of the primary hepatocytes isolated with this p...
Various primary hepatocyte isolation protocols have been developed. They also have been kept optimized and adapted based on different needs (Table 1). Isolation protocols are generally composed of two parts: perfusion (including enzyme digestion) and purification.
The perfusion can be performed with the entire liver in vivo2,20,21,22,
The authors have nothing to disclose.
This work was supported by the National Institutes of Health (Grant 5R01HD095512-02 to S.W.).
Name | Company | Catalog Number | Comments |
1x PBS | Gibco | 10010023 | |
10x HBSS | Gibco | 14065-056 | |
12-well Plate | FALCON | 353043 | Coating not required |
6-well Plate | FALCON | 353046 | Coating not required |
anti-AKT | Cell Signaling | 2920S | |
Antibiotic Antimycotic Solution (100x), Stabilized | Sigma-Aldrich | A5955 | |
anti-FOXO1 | Cell Signaling | 97635S | |
anti-GAPDH | Cell Signaling | 2118S | |
anti-p-AKT (S473) | Cell Signaling | 9271L | |
anti-PEPCK | Santa Cruz | SC-166778 | |
anti-p-FOXO1 (S256) | Cell Signaling | 84192S | |
Cell Strainer, 70 µm | CELLTREAT | 229483 | |
Closed IV Catheter, 24 Gauge 0.75 IN | Becton Dickinson | 383511 | |
DMEM, no glucose, no glutamine, no phenol red | ThermoFisher Scientific | A1443001 | |
EnzyChrom Glucose Assay Kit | BioAssay Systems | EBGL-100 | |
Fetal Bovine Serum (FBS) | Hyclone | SH30071.03 | |
Forskolin | MilliporeSigma | F3917-10MG | |
Glucagon | Sigma-Aldrich | G2044 | |
Goat Anti-mouse IgG Secondary Antibody | LI-COR | 926-68070 | |
Goat Anti-rabbit IgG Secondary Antibody | LI-COR | 926-32211 | |
GraphPad Prism 8 | GraphPad Software | NA | |
Hepatocyte Wash Medium | Gibco | 17704-024 | |
IBMX | Cell Signaling | 13630S | |
Insulin | Lilly | NDC 0002-8215-01 | |
Ketamine HCL (100 mg/mL) | Hospira Inc | NDC 0409-2051-05 | |
L-Glutamine | Gibco | 25030081 | |
Liver Digest Medium | Gibco | 17703-034 | Aliquot within tissue culture hood to 25 mL each in 50 mL tube, and keep in -20 °C freezer |
Liver Perfusion Medium | Gibco | 17701-038 | |
Pen Strep | Gibco | 15140122 | |
Percoll | GE Healthcare | 17-0891-01 | |
Peristaltic Pump | Gilson | Minipuls 2 | Capable of pumping at 4 mL/min |
Petri Dish | Fisherbrand | 08-757-12 | |
Refrigerated Centrifuge | Sorvall | Legend RT | Capable to centrifuge 50 mL tube at 4 °C |
Sodium L-Lactate | Sigma-Aldrich | L7022 | |
Sodium Pyruvate | Gibco | 11360070 | |
Syringe Filter, PVDF 0.45 µm 30mm diameter | CELLTREAT | 229745 | |
Syringe, 0.5 mL | Becton Dickinson | 329461 | |
Syringe, 60 mL | Becton Dickinson | 309653 | |
Trypan Blue Solution, 0.4% | Gibco | 15250061 | |
Tube, 15 mL | Corning | 430052 | |
Tube, 50 mL | Corning | 430290 | |
Water Bath Tank | Corning | CLS6783 | Or any water bath tank capable of heating up to 45 °C |
William’s E Medium (GlutaMAX Supplement) | Gibco | 32551020 | |
Xylozine (100 mg/mL) | Vetone Anased LA | NDC13985-704-10 |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone